Tuersunayi Abudureheman

CDK7 Inhibitor THZ1 Induces the Cell Apoptosis of B-Cell Acute Lymphocytic Leukemia by Perturbing Cellular Metabolism

Tuersunayi Abudureheman, Jing Xia, Ming-hao Li, 2021, Frontiers in Oncology.

CDK9 Inhibitor Induces the Apoptosis of B-Cell Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolytic Metabolism

Tuersunayi Abudureheman, Jing Xia, Ming-hao Li, 2021, Frontiers in Cell and Developmental Biology.

Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis

Bin-Bing S. Zhou, Tuersunayi Abudureheman, Hang Zhou, 2020, Medical science monitor : international medical journal of experimental and clinical research.

A novel His-tag-binding aptamer for recombinant protein detection and T cell-based immunotherapy.

Tuersunayi Abudureheman, Hang Zhou, Weiwei Zheng, 2023, Talanta: The International Journal of Pure and Applied Analytical Chemistry.

Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment

Tuersunayi Abudureheman, Weiwei Zheng, Li-Ting Yang, 2023, Cancer Immunology, Immunotherapy.

CAR‐Aptamers Enable Traceless Enrichment and Monitoring of CAR‐Positive Cells and Overcome Tumor Immune Escape

Tuersunayi Abudureheman, Weiwei Zheng, Li-Ting Yang, 2023, Advanced science.